Dive into the research topics of Coronary aneurysm associated with coronary perforation after sirolimus-eluting stents ... Coronary aneurysm associated with coronary perforation after sirolimus-eluting stents implantation: Close follow-up exceeding 2 ... Coronary aneurysm associated with coronary perforation after sirolimus-eluting stents implantation: Close follow-up exceeding 2 ... Coronary aneurysm associated with coronary perforation after sirolimus-eluting stents implantation : Close follow-up exceeding ...

Dive into the research topics of Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting ... T1 - Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based ... Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based ... This study reports long-term results of the LIPSIA Yukon trial which compared the polymer-free sirolimus-eluting Yukon Choice ...

T2 - The ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting ... Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting ... Dive into the research topics of Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for ... Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting ...

Objectives The aim of the merit-3 study was to determine the safety and performance of the BioMime Sirolimus-Eluting Coronary ... N2 - Objectives The aim of the merit-3 study was to determine the safety and performance of the BioMime Sirolimus-Eluting ... AB - Objectives The aim of the merit-3 study was to determine the safety and performance of the BioMime Sirolimus-Eluting ... Dive into the research topics of One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable ...

... have been shown to improve clinical outcomes compared with early-generation sirolimus-eluting (SES) and paclitaxel-eluting ... Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary ... Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary ... have been shown to improve clinical outcomes compared with early-generation sirolimus-eluting (SES) and paclitaxel-eluting ...

Shitrit, D., Rahamimov, R., Gidon, S., Bakal, I., Bargil-Shitrit, A., Milton, S., & Kramer, M. R. (2005). Use of sirolimus and ... Shitrit, D, Rahamimov, R, Gidon, S, Bakal, I, Bargil-Shitrit, A, Milton, S & Kramer, MR 2005, Use of sirolimus and low-dose ... Sirolimus, a macrolide immunosuppressant with a distinct mechanism of action, may prevent renal failure but was found to have a ... Sirolimus, a macrolide immunosuppressant with a distinct mechanism of action, may prevent renal failure but was found to have a ...

Impact of Lesion Length on Outcomes After Revascularization with Everolimus- and Sirolimus Eluting stents.: A Substudy of the ...

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic ... Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily ... Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus- ... Biodegradable polymer-coated thin strut sirolimus- -eluting stent versus durable polymer-coated everolimus-eluting stent in the ...

Evaluation of the cost utility of sirolimus versus tacrolimus for immunosuppression for renal transplantation in the United ... Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the ... Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in ...

Thymoglobulin induction with sirolimus maintenance therapy permitted immunosuppression minimization in selected pancreas ... Thymoglobulin induction with sirolimus maintenance therapy permitted immunosuppression minimization in selected pancreas ... Thymoglobulin induction with sirolimus maintenance therapy permitted immunosuppression minimization in selected pancreas ... Thymoglobulin induction with sirolimus maintenance therapy permitted immunosuppression minimization in selected pancreas ...

Extended release of sirolimus from stents has been proven highly efficacious in both coronary and peripheral vasculatures. ... "MedAlliance is honoured to have our sirolimus DEB selected for the FDAs Breakthrough Device Program for a fourth time. This ... InBreakthrough Device, De Novo Coronary Lesions, Drug-Eluting Balloon, FDA, MedAlliance, Sirolimus ... MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo ...

This study sought to assess the safety and efficacy of the Nano polymer-free sirolimus-eluting stent (SES) in the treatment of ... Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer ... sirolimus-eluting stent for coronary artery disease: the Nano randomized trial-Adcanced Medical Technologles_Cardiovascular ... This study sought to assess the safety and efficacy of the Nano polymer-free sirolimus-eluting stent (SES) in the treatment of ...

Topical sirolimus for the treatment of facial angiofibromas in tuberous sclerosis patient: a case report Authors. * Ankit ... Sirolimus is a lipophilic lactone isolated from Streptomyces hygroscopicus (soil bacteria), found to have anti-T-cell ... Sirolimus (rapamycin): From thesoil of Easter Island to a bright future. J Am Acad Dermatol. 2007;57(6):1046-50. ... Sirolimus binds with mTOR and causes inhibition of mTOR activity and VEGF‑stimulated endothelial cell proliferation. Topical ...

A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the ... A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the ... A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the ... with the durable polymer sirolimus-eluting Cypher stent (DP-SES) in women undergoing percutaneous coronary intervention (PCI). ...

Comparison of in-hospital mortality for PCI patients receiving DES comparing sirolimus vs paclitaxel with or without acute ... 2005). Comparison of in-hospital mortality for PCI patients receiving DES comparing sirolimus vs paclitaxel with or without ... 2005). Comparison of in-hospital mortality for PCI patients receiving DES comparing sirolimus vs paclitaxel with or without ...

... improve clinical outcome compared to early generation sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES). We ... Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel- ... Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel- ... Background Newer generation everolimus-eluting stents (EES) improve clinical outcome compared to early generation sirolimus- ...

NCT04094675: Sirolimus for Cowden Syndrome. With Colon Polyposis. This study is looking at the effect of the drug sirolimus on ...

... sirolimus (Rapamune); sofosbuvir and velpatasvir (Epclusa); sofosbuvir, velpatasvir, and voxilaprevir (Vosevi); tacrolimus ( ...

Sirolimus is a potent inhibitor of mTOR. Based on work I did in the lab, and based on the data in front of me that my mTOR ... Sirolimus, also called rapamycin, is a drug that was never intended for Castlemans and had never been used before for ...

Sirolimus: A Therapeutic Advance for Dermatologic Disease. Sirolimus, also known as rapamycin (SRL, Rapamune®), was approved in ...

Sirolimus: A Therapeutic Advance for Dermatologic Disease. Imiquimod 5% Cream (Aldara®) in the Treatment of Basal Cell ...

Sirolimus plus tacrolimus was associated with a better median survival than MMF plus tacrolimus (8.9 years vs 7.1 years). ... One downside for sirolimus, though, is that it interferes with wound healing, a potentially life-threatening complication if ... They singled out an immunosuppressive drug called sirolimus, in a class of drugs called cell cycle inhibitors, based on a few ... "Sirolimus is relatively novel in lung transplantation. Physicians and surgeons in the transplant community have little ...

sirolimus (e.g. Rapamune), a medicine used in transplant patients.. *efavirenz (e.g. Stocrin) (a medicine used to treat HIV ... sirolimus (e.g. Rapamune) a medicine used in transplant patients.. *efavirenz (Stocrin) (a medicine used to treat HIV infection ...

sirolimus. *tacrolimus. *velpatasvir. *warfarin If you are taking any of these medications, speak with your doctor or ...

Sirolimus. Translation genetic. Western Blotting. Abstract in English. Background: Renal cell carcinoma (RCC) is an increasing ...

sirolimus. *tacrolimus. *warfarin. If you are taking any of these medications, speak with your doctor or pharmacist. Depending ...

... sirolimus; temsirolimus) - Legemiddelinteraksjon med cannabidiol som fører til økte serumkonsentrasjoner og økt toksisitet av ...

AACC also recommends that CMS set a target value of ± 20% for cyclosporine, everolimus, tacrolimus, sirolimus, and methotrexate ... sirolimus; and methotrexate. We further support the removal of ethosuximide, LDH isoenzymes, primidone, procainamide/NAPA, and ...

Mint-Amlodipine: Amlodipine belongs to the family of medications known as calcium channel blockers. Amlodipine is used to treat high blood pressure and angina (chest pain). It works to control blood pressure and reduces the number of angina attacks by widening and relaxing blood vessels.

Teva-Cilazapril-HCTZ: This combination product contains two active medications: cilazapril and hydrochlorothiazide. Cilazapril belongs to the class of medications called ACE inhibitors. It works by relaxing blood vessels and helping the heart to pump blood that carries oxygen to the different parts of the body more efficiently. Hydrochlorothiazide belongs to the class of medications called thiazide diuretics or water pills, which help control blood pressure by getting rid of excess salt and water.